Esco Aster News & Events

Corporate Press Release

Esco Aster will be Presenting at BPI Digital Week
Esco Aster, a CDMO company headquartered in Singapore is partnering with BioProcess International Digital Week on December 7-10 to conduct a webinar on optimizing stem cell cultures. ...
Read more

December 02, 2020

ESCO ASTER ENTERS INTO MOU WITH AUSTRIA’S NUVONIS TECHNOLOGIES TO SUPPORT NOVEL VIRAL VACCINES IN ASIA

Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for the early development and manufacturing of viral vaccines prevalent ...
Read more

October 04, 2018

ESCO ASTER AND WUHAN BIO-RAID BIOTECHNOLOGY ESTABLISH MEMORANDUM OF UNDERSTANDING FOR LENTIVIRAL VECTOR PLATFORM TO SUPPORT CAR-T PIPELINE IN CHINA

SINGAPORE AND CHINA, July 19, 2018 – Esco Aster, a contract development and manufacturing organization (CDMO) of Esco Group, today announced the launch of lentiviral vector pla ...
Read more

July 19, 2018

ESCO ASTER AND KONKUK UNIVERSITY COOPERATE ON PIG VACCINES IN ASIA

SINGAPORE AND KOREA, July 01, 2018 – Esco Aster, a leading independent contract development and manufacturing organization with its patent Tide Motion bioreactor technology, has signed a coll ...
Read more

July 01, 2018

AN EXCLUSIVE INTERVIEW WITH ESCO – FROM CLEANROOMS TO CONTAINMENT SYSTEMS

Esco Group is a Singapore-based life science company with a diversified portfolio and sales in over 100 countries. As a leading manufacturer of laborat ...
Read more

June 20, 2018

There's More to Canada!

Esco Aster, alongside with Esco VacciXcell will be back for the upcoming International Society for Cell Therapy (ISCT) 2018 at Palais Des Congres de Montreal, Canada from May 2 &nd ...
Read more

April 26, 2018

Esco Aster and Esco VacciXcell Made It West!

Esco Aster, a leading CDMO company in ASEAN that utilizes Esco VacciXcell’s Tide Motion technology, jump started the year right. The recently held World Vaccine Congress at Renaissance Hotel, ...
Read more

April 24, 2018

ESCO ASTER AND MAX PLANCK INSTITUTE COOPERATE ON RESEARCH OF HUMAN FLAVIVIRUS VACCINES

Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a cooperation agreement with the Max Pl ...
Read more

April 01, 2018

VISIT BY MINISTER FOR NATIONAL DEVELOPMENT AND SECOND MINISTER FOR FINANCE, LAWRENCE WONG, TO ESCO SINGAPORE

Esco Group, a renowned Singapore-based life science company, hosted a visit by the Minister for National Development and Second Minister for Finance, Mr Lawrence Wong on 31st January 201 ...
Read more

January 31, 2018

ESCO ASTER AND NATIONAL UNIVERSITY OF SINGAPORE ANNOUNCE A DEVELOPMENT OF 3D ORGANOIDS MINIATURE BIOREACTOR
Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a research collaboration agreement with De ...
Read more

January 29, 2018

ESCO ASTER AND NATIONAL UNIVERSITY OF SINGAPORE ANNOUNCE A DEVELOPMENT OF SINGLE-USE BIOREACTOR-BASED STEM CELLS
Esco Aster, a leading independent contract development and manufacturing organization underpinned by its patent Tide Motion bioreactor technology, has signed a technology development agreement with Na ...
Read more

January 08, 2018

ESCO ASTER AND BIOPROCESSING TECHNOLOGY INSTITUTE SIGN MEMORANDUM OF UNDERSTANDING TO INNOVATE ON CONTINUOUS BIOMANUFACTURING PLATFORM
Esco Aster, a leading independent contract development and manufacturing organization dedicated to Singapore’s R&D ecosystem, has signed a Memorandum of Understanding (MOU) with A*STAR&rsquo ...
Read more

December 18, 2017

ESCO ASTER AND INSTITUTE OF MOLECULAR CELL BIOLOGY ANNOUNCE A COLLABORATION TO ACCELERATE PRECLINICAL DEVELOPMENT OF A HAND FOOT AND MOUTH VACCINE
Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has signed a research collaboration agreement with A*STAR's Institute ...
Read more

December 07, 2017

ESCO ASTER UNVEILED NEW AND IMPROVE TIDECELL® AT A*STAR SCIENTIFIC BIOPOLIS ROADSHOW
Esco Aster, a leading independent contract development and manufacturing organization dedicated to the Singapore's R&D ecosystem, has unveiled its new and improved TideCell®, CelCradle™ and ...
Read more

November 30, 2017

Imagine the Possibilities: From Science to Society
Esco Aster is strengthening its core in bioprocessing for being one of the exhibitors of the upcoming Research Support Center Scientific Roadshow on November 14, 2017, starting from 9:30 am to 3:30 pm ...
Read more

November 08, 2017

Introducing Esco Aster Contract Development and Manufacturing Organization (CDMO)
A CDMO or Contract Development and Manufacturing Organization is a contractual company that provides services like drug development and drug manufacturing in the healthcare industry. CDMO services run ...
Read more

June 15, 2017

Technology & Solution News

ISCT 2020 Paris Virtual Event Appreciation

Esco Aster was recently live at the ISCT 2020 Paris Virtual event from May 28 to May 29. We would like tot thank all for viisting our virtual booth and viewing our poster on "Large Scale 3D Biore ...
Read more

June 03, 2020

Mesenchymal Stromal Cells in the treatment of COVID-19

The COVID-19 pandemic ravages healthcare systems globally, giving impetus for research institutes around the world to explore a widespread of clinical solutions to aid recovery ...
Read more

May 27, 2020

Esco Aster Gathers Key Collaborators to Advance Mobile Diagnostic Labs Aster Xpress™ in Singapore and Globally

SINGAPORE - The recently launched Esco Aster Mobile Diagnostic Lab Aster Xpress™ is the first and till date a commercially available, turnkey solution, vertically integrated wi ...
Read more

May 18, 2020

Esco Aster Launches Modular Isolation Rooms for COVID-19

Esco was the first company in 1978 to build isolation rooms in Singapore and the whole ASEAN region; with its collective 42 years of experience, it is proud to launch the Read more

April 23, 2020

COVID-19 Test Timings: What is the recommended test and when should it be performed?

The key message “Test, Test, Test” delivered by the WHO Director-General, Dr. Tedros Ghebreyesus, last Mar. 16 was directed for all countries; testing every suspect ...
Read more

April 17, 2020

Esco Aster Launches Phase 1 COVID-19 Swab Booths of Trace, Test, and Treat Platform

Esco Aster launches phase 1 of its end to end Trace, Test, and Treat Platform starting with COVID-19 swab booths. ...
Read more

April 15, 2020

Esco Aster End to End Platform, DX, Therapeutics and Vaccines, Self-Sufficiency in CoVID-19 Pandemic

As various countries around the world are working in unity to control the CoVID outbreak and flatten the disease curve, Esco Aster has been working untiringly since patient zer ...
Read more

March 23, 2020

Kết quả thử nghiệm công nghệ TideMotion bởi Esco Aster bản tiếng Việt
(Esco Aster Releases Vietnamese-Translated Tide Motion Data to the Public)

Esco Aster không ngừng vươn tầm nhìn và nỗ lực với sứ mệnh tạo ra các công nghệ cho phép tự sản xuất vắc-xin, thuốc sinh học tương tự (biosimilar) , liệu pháp gen, liệu pháp c ...
Read more

December 11, 2019

ARE YOUR COSMETICS DOING ENOUGH?

With millions of aging baby boomers, the hottest trend in the skin care industry is cosmeceuticals. Cosmeceuticals are topical cosmetic-pharmaceutical hybrids containi ...
Read more

December 04, 2019

Esco Aster: At The Forefront of Cell and Gene Therapies

SINGAPORE - Esco Aster, the Contract Development and Manufacturing Organization (CDMO) subsidiary of Esco Group of Companies, is poised for growth as we continue the outfitting ...
Read more

November 29, 2019

Esco Aster launches our latest CelCradle X in Singapore Stem Cell Society Symposium (SCSS)together with International Society of Cell & Gene Therapy (ISCT)

SINGAPORE – Esco Aster, the contract development and manufacturing organization (CDMO) subsidiary of Esco Group of Companies, completed the re-engineering of a Tide Motion ...
Read more

November 13, 2019

BIOACTIVE PEPTIDES: Applications and Our Solutions!

Biopeptides are organic, isolated small fragments formed by amino acids joined by amides or peptide bonds and derived mainly from food proteins like hydrolysates, shellfish, fu ...
Read more

November 04, 2019

Esco Aster’s Aseptic and/or Potent Processing with cGMP Isolators

SINGAPORE – Esco Aster, the cGMP contract development and manufacturing organization (CDMO) subsidiary of Esco Group of companies, continues to provide turnkey manufacturing so ...
Read more

October 14, 2019

ESCO ASTER AND A*STAR’S BIOPROCESSING TECHNOLOGY INSTITUTE TO ADVANCE BIOPROCESSING TECHNOLOGIES FOR CELL AND GENE THERAPIES

SINGAPORE – Esco Aster, a contract development and manufacturing organisation (CDMO) of Esco Group, today announced the official opening of the BTI–ESCO ASTER Centre of Excelle ...
Read more

January 24, 2019

LAUNCH OF TECHNOLOGY WORKSHOP TO SUPPORT INDUSTRY DRIVE TOWARDS BIOPROCESSING

SINGAPORE – Esco Aster, a contract development and manufacturing organisation (CDMO) and leader in bioprocessing technology, announced today the launch of Technology Workshop “ ...
Read more

January 15, 2019

ESCO ASTER JOINS BIO-PROCESS SYSTEM ALLIANCE

Esco Aster Singapore is now a member of the international Bio-Process System Alliance (BPSA), an industry group promoting the implementation of single-use systems for biotherap ...
Read more

October 24, 2018

Upcoming Events